medigraphic.com
ISSN 1029-3019 (Electronic)

2022, Number 04

<< Back Next >>

MediSan 2022; 26 (04)

Manual flowmetry in the clinical and therapeutic evaluation of patients with benign prostatic hyperplasia

León EA

Language: Spanish
References: 13
Page:
PDF size: 765.76 Kb.


ABSTRACT

Introduction: The benign prostatic hyperplasia is a frequent disease that increases its incidence with the age. Its pathogenesis is not still clear and its typical clinical pattern is the progressive urinary obstruction with loss of life quality.
Objectives: To evaluate the predictive value of manual flowmetry in the definition of the therapeutic behavior in patients with benign prostatic hyperplasia and to determine the evolution of these patients as time goes by.
Method: A descriptive, prospective and longitudinal study of 50 patients diagnosed with benign prostatic hyperplasia was carried out, from the clinical and imaging points of view, who were assisted in Saturnino Lora Torres Teaching Provincial Clinical Surgical Hospital in Santiago de Cuba, from January, 2017 to the same period in 2019.
Results: The manual flowmetry carried out demonstrated at the beginning that 62.0 % of the sample had a rate of average urinary flow below the physiologic range and 22.0 % was in bordering or doubtful range. Thirty seven patients received surgical treatment (74.0 %); thirteen patients (26.0 %) received medication and with clinical follow up. The transurethral resection of prostate was carried out with a quick recovery of the patients and there were complications just in a 2.0 %.
Conclusions: The manual flowmetry was useful to determine what to do in most of the studied patients and in the short term follow up of those who were operated.


REFERENCES

  1. Scott McDougal W, Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell-Walsh Urology. 11 ed. España: Elsevier Inc; 2016.

  2. Caravia Pubillones I, Vela Caravia I. Uroflujometría. Actualización del tema. Rev. cuban. urol. 2015 [citado 03/04/2020]; 4(1). Disponible en: http://www.revurologia.sld.cu/index.php/rcu/article/view/228/2302.

  3. Cuba. Ministerio de Salud Pública. Anuario estadístico de salud 2018. La Habana: MINSAP; 2019.

  4. McAninch JW, Lue TF. Smith y Tanagho. Urología General. 18 ed. Bogotá: Editorial McGraw-Hill, Interamericana Editores SA; 2013.

  5. Errando Smet C, Müller Arteaga C, Hernández M, Roset M. Diagnóstico y tratamiento del paciente varón con síntomas del tracto urinario inferior en España- Estudio MERCURY. ¿Seguimos los urólogos las recomendaciones de las guías europeas? Actas Urol Esp. 2018 [citado 03/04/2020]; 42(5):323-30. Disponible en: https://www.elsevier.es/es-revista-actas-urologicas-espanolas-292-articulo-diagnostico-tratamiento-del-paciente-varon-S02104806183000445.

  6. Alcántara Montero A, López de Alda González A. ¿Puede predecir la medición de la protrusión prostática intravesical la respuesta al tratamiento médico en pacientes con hiperplasia benigna de próstata? Luces y sombras. Actas Urol Esp. 2018 [citado 03/04/2020]; 42(8):542-3. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S02104806183006406.

  7. Manual de Prácticas Médicas del Hospital "Hermanos Ameijeira". 4 ed. La Habana: Hospital "Hermanos Ameijeira"; 2012.

  8. Szemat R. Uretra, próstata y vejiga. Endoscopia. Bogotá: Editorial interamericana SA; 2014.

  9. Alcántara Montero A, Fernández Fernández L. Guías clínicas para los síntomas del tracto urinario inferior en el varón e hiperplasia benigna de próstata: importancia de las actualizaciones periódicas según la evidencia disponible. Actas Urol Esp. 2018 [citado 03/04/2020]; 42(4): 280-1. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S02104806173022069.

  10. Foster HE, Dahm P, Kohler TS, Lerner LB, Parsons JK, Wilt TJ, et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. J Urol. 2019 [citado 03/04/2020]; 202(3): 592-8. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/3105966810.

  11. Plante M, Gilling P, Barber N, Bidair M, Anderson P, Sutton M, et al. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial. BJU Int. 2019; 123(4):651-60.

  12. Tobia I, Favre G, Olivares AM, Giúdice C. Uroflujometría como test diagnóstico de reestenosis uretral en población menor a 50 años de edad. Rev. Arg. de Urol. 2017 [citado 03/04/2020]; 82(2):64-9. Disponible en: https://www.researchgate.net/profile/Ignacio_Tobia-Gonzalez/publication/321245065_Uroflujometria_como_test_diagnostico_de_reestenosis_uretral_en_poblacion_menor_a_50_anos_de_edad/links/5aec38480f7e9b01d3e075c0/Uroflujometria-como-test-diagnostico-de-reestenosis-uretral-en-poblacion-menor-a-50-anos-de-edad.pdf12.

  13. Alcántara Montero A. Efecto de los inhibidores de la 5-alfa-reductasa sobre la función sexual: nuevas aportaciones. Actas Urol Esp. 2017 [citado 03/04/2020]; 41(4):279-80. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=595991913.




2020     |     www.medigraphic.com